SOD1 and amyotrophic lateral sclerosis: The current research study provides evidence that administering niclosamide effectively mitigates a broad spectrum of disease features associated with ALS in both SOD1-G93A and FUS transgenic mouse models, characterised by different molecular disease determinants.